Clinical Trial Update: Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating atezolizumab with or without cobimetinib in unresectable gallbladder carcinoma and metastatic cholangiocarcinoma; study completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Gallbladder Carcinoma
• Intrahepatic Cholangiocarcinoma Ajcc V8
• Unresectable Cholangiocarcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Cobimetinib (cobimetinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Gallbladder Carcinoma, Metastatic Cholangiocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2023-07-11